|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
2006-6-22
|
|
pubmed:abstractText |
We conducted a double-blind, randomized, placebo-controlled trial to determine the effects of oral cyclophosphamide on lung function and health-related symptoms in patients with evidence of active alveolitis and scleroderma-related interstitial lung disease.
|
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/5M01 RR 00865,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 50550,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60587,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60597,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60606,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60682,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60748,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60750,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60794,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60823,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60838,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60839,
http://linkedlifedata.com/resource/pubmed/grant/UO1 HL 60895
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:ArriolaEdgarE,
pubmed-author:BolsterMarcyM,
pubmed-author:ClementsPhilip JPJ,
pubmed-author:ConnollyM KariMK,
pubmed-author:ElashoffRobertR,
pubmed-author:FesslerBarriB,
pubmed-author:FurstDaniel EDE,
pubmed-author:GoldenJeffreyJ,
pubmed-author:GoldinJonathanJ,
pubmed-author:HsuVivien MVM,
pubmed-author:MayesMaureenM,
pubmed-author:MeterskyMarkM,
pubmed-author:MubarakKamalK,
pubmed-author:OlmanMitchellM,
pubmed-author:ParsleyEdE,
pubmed-author:ReadCharlesC,
pubmed-author:RileyDavid JDJ,
pubmed-author:RothMichael DMD,
pubmed-author:RothfieldNaomiN,
pubmed-author:SchraufnagelDean EDE,
pubmed-author:Scleroderma Lung Study Research Group,
pubmed-author:SeiboldJames RJR,
pubmed-author:SilverRichardR,
pubmed-author:SimmsRobertR,
pubmed-author:SteenVirginiaV,
pubmed-author:StrangeCharlieC,
pubmed-author:TashkinDonald PDP,
pubmed-author:TheodoreArthurA,
pubmed-author:VargaJohnJ,
pubmed-author:WhiteBarbaraB,
pubmed-author:WigleyFredrickF,
pubmed-author:WiseRobertR
|
|
pubmed:copyrightInfo |
Copyright 2006 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
22
|
|
pubmed:volume |
354
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2655-66
|
|
pubmed:dateRevised |
2010-6-10
|
|
pubmed:meshHeading |
pubmed-meshheading:16790698-Administration, Oral,
pubmed-meshheading:16790698-Adult,
pubmed-meshheading:16790698-Aged,
pubmed-meshheading:16790698-Aged, 80 and over,
pubmed-meshheading:16790698-Autoimmune Diseases,
pubmed-meshheading:16790698-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:16790698-Cyclophosphamide,
pubmed-meshheading:16790698-Double-Blind Method,
pubmed-meshheading:16790698-Female,
pubmed-meshheading:16790698-Humans,
pubmed-meshheading:16790698-Immunosuppressive Agents,
pubmed-meshheading:16790698-Leukopenia,
pubmed-meshheading:16790698-Lung Diseases, Interstitial,
pubmed-meshheading:16790698-Male,
pubmed-meshheading:16790698-Middle Aged,
pubmed-meshheading:16790698-Regression Analysis,
pubmed-meshheading:16790698-Respiratory Function Tests,
pubmed-meshheading:16790698-Scleroderma, Systemic,
pubmed-meshheading:16790698-Treatment Outcome,
pubmed-meshheading:16790698-Vital Capacity
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Cyclophosphamide versus placebo in scleroderma lung disease.
|
|
pubmed:affiliation |
University of California at Los Angeles, Los Angeles, USA. dtashkin@mednet.ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
